Active Ingredient(s): Metyrapone
FDA Approved: * December 4, 1961
Pharm Company: * NOVARTIS
Category: Diagnostic Aid

Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 3 Chemistry 4 Research 5 See also 6 References Medical uses Metyrapone can be used in the diagnosis of adrenal insufficiency. Metyrapone 30mg/kg, maximum dose 3,000mg, is administered at midnight usually with a snack. The plasma ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Metopirone 250 mg Oral Capsule
NDC: 76336-455
Hra Pharma